Floatz logo

Gm-Csf Secreting Leukemia Vaccine

Myelodysplastic Syndrome RAEB-I or RAEB-II

Dana-Farber Cancer InstitutevaccineN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
95/ 100

Competitive context

33 Active assets in the Myelodysplastic Syndrome RAEB-I or RAEB-II cohort.

Asset / SponsorPhaseRating
Cytosin-Arabinosid
University of Southern California
Phase 3BBB
Fludarabine
Fred Hutchinson Cancer Center
Phase 3BB
TACROLIMUS
Fred Hutchinson Cancer Center
Phase 2BB
CYCLOSPORIN A
Fred Hutchinson Cancer Center
Phase 2BB
ETOPOSIDE
M.D. Anderson Cancer Center
Phase 3BB

View all 50 →

Same molecule, other indications

Gm-Csf Secreting Leukemia Vaccine is also rated in:

acute myeloid leukemiaDormant
D
Indicative ·
30 / 100
View asset →
blast phase chronic myelogenous leukemia, BCR-ABL1 positiveDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →